Chargement en cours...

Tumor-Associated Lymphocytes and Increased FoxP3(+) Regulatory T Cell Frequency Correlate with More Aggressive Papillary Thyroid Cancer

Context: Ten to 30% of patients with papillary thyroid cancer (PTC) develop recurrent disease and may benefit from innovative adjuvant therapies. Immune-based therapies are under investigation to treat many types of cancer. The role of the immune system in PTC is poorly understood. Objective: We inv...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: French, Jena D., Weber, Zachary J., Fretwell, Deborah L., Said, Sherif, Klopper, Joshua P., Haugen, Bryan R.
Format: Artigo
Langue:Inglês
Publié: The Endocrine Society 2010
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2869546/
https://ncbi.nlm.nih.gov/pubmed/20207826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2009-2564
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!